交易 Qiagen NV - QIA CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
价差 | 0.130 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.022046% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | -0.000176% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | EUR | ||||||||
保证金 | 5% | ||||||||
上市交易所 | Germany | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Qiagen NV ESG Risk Ratings
High Medium Low Negligible
'A' 分數表示相對 ESG 表現優異,公開報告重要 ESG 數據的透明度高
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Dec 1, 2023 | 37.945 | 0.510 | 1.36% | 37.435 | 37.955 | 37.405 |
Nov 30, 2023 | 37.655 | 0.420 | 1.13% | 37.235 | 37.705 | 37.235 |
Nov 29, 2023 | 37.575 | 0.450 | 1.21% | 37.125 | 37.765 | 37.055 |
Nov 28, 2023 | 37.065 | 0.190 | 0.52% | 36.875 | 37.215 | 36.755 |
Nov 27, 2023 | 37.155 | 0.080 | 0.22% | 37.075 | 37.655 | 37.075 |
Nov 24, 2023 | 37.245 | -0.120 | -0.32% | 37.365 | 37.605 | 37.125 |
Nov 23, 2023 | 37.465 | 0.120 | 0.32% | 37.345 | 37.535 | 37.035 |
Nov 22, 2023 | 37.525 | 0.570 | 1.54% | 36.955 | 37.595 | 36.915 |
Nov 21, 2023 | 36.865 | 0.785 | 2.18% | 36.080 | 36.895 | 36.080 |
Nov 20, 2023 | 36.110 | -0.010 | -0.03% | 36.120 | 36.485 | 36.020 |
Nov 17, 2023 | 36.110 | 0.035 | 0.10% | 36.075 | 36.595 | 36.075 |
Nov 16, 2023 | 36.270 | 0.220 | 0.61% | 36.050 | 36.425 | 36.050 |
Nov 15, 2023 | 36.455 | 0.170 | 0.47% | 36.285 | 36.855 | 36.010 |
Nov 14, 2023 | 36.365 | 0.615 | 1.72% | 35.750 | 36.685 | 35.750 |
Nov 13, 2023 | 35.790 | 0.380 | 1.07% | 35.410 | 35.840 | 35.310 |
Nov 10, 2023 | 35.140 | -0.260 | -0.73% | 35.400 | 35.690 | 35.020 |
Nov 9, 2023 | 35.910 | -0.110 | -0.31% | 36.020 | 36.395 | 35.840 |
Nov 8, 2023 | 36.305 | 0.020 | 0.06% | 36.285 | 36.695 | 36.285 |
Nov 7, 2023 | 36.485 | 0.575 | 1.60% | 35.910 | 36.655 | 35.890 |
Nov 6, 2023 | 36.260 | -0.165 | -0.45% | 36.425 | 36.595 | 36.210 |
Qiagen NV Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Tuesday, December 12, 2023 | ||
时间(协调世界时) (UTC) 13:00 | 国家 NL
| 事件 Qiagen NV at Exane BNPP Diagnostics, Imaging & Life Sciences CEO Conference (Virtual) Qiagen NV at Exane BNPP Diagnostics, Imaging & Life Sciences CEO Conference (Virtual)Forecast(预报) -上一页 - |
Monday, February 5, 2024 | ||
时间(协调世界时) (UTC) 21:05 | 国家 NL
| 事件 Q4 2023 Qiagen NV Earnings Release Q4 2023 Qiagen NV Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 2141.52 | 2251.66 | 1870.35 | 1526.42 | 1501.85 |
收入 | 2141.52 | 2251.66 | 1870.35 | 1526.42 | 1501.85 |
收入成本,共計 | 756.955 | 800.837 | 637.631 | 521.162 | 499.271 |
毛利 | 1384.56 | 1450.82 | 1232.71 | 1005.26 | 1002.58 |
總營業費用 | 1610.06 | 1621.57 | 1483.92 | 1547.76 | 1235.27 |
銷售/一般/行政費用,總計 | 603.945 | 584.468 | 525.362 | 505.268 | 508.146 |
研究與開發 | 189.859 | 189.964 | 149.072 | 157.448 | 161.852 |
Depreciation / Amortization | 14.531 | 18.542 | 20.811 | 29.973 | 39.032 |
異常費用(收入) | 44.768 | 27.762 | 151.039 | 333.91 | 26.966 |
營業收入 | 531.46 | 630.084 | 386.431 | -21.337 | 266.581 |
利息收入(費用),非經營淨值 | -19.1 | -5.122 | -59.918 | -43.696 | -70.168 |
其他,淨值 | 0.241 | 0.871 | 112.959 | -12.743 | 29.324 |
稅前淨收入 | 512.601 | 625.833 | 439.472 | -77.776 | 225.737 |
稅後淨收入 | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
少數股東權益 | 0 | ||||
未計算非常項目前的淨收益 | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
淨收入 | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
普通股股東可獲收益 (不含非經常性項目) | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
普通股股東可獲收益 (含非經常性項目) | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
攤薄調整 | 0 | ||||
攤薄淨收入 | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
攤薄後加權平均股 | 230.136 | 232.034 | 234.214 | 226.777 | 233.456 |
扣除特別項目的每股攤薄盈利 | 1.83896 | 2.20915 | 1.53359 | -0.1828 | 0.81549 |
每股正常攤薄盈利 | 1.99957 | 2.30715 | 2.00343 | 0.77427 | 0.9129 |
非常規項目總計 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 494.857 | 485.398 | 497.984 | 499.631 | 515.512 |
收入 | 494.857 | 485.398 | 497.984 | 499.631 | 515.512 |
收入成本,共計 | 182.705 | 177.922 | 180.46 | 178.58 | 184.494 |
毛利 | 312.152 | 307.476 | 317.524 | 321.051 | 331.018 |
總營業費用 | 389.425 | 388.688 | 393.411 | 401.972 | 393.355 |
銷售/一般/行政費用,總計 | 145.523 | 147.58 | 154.211 | 145.462 | 151.418 |
研究與開發 | 49.893 | 54.718 | 44.719 | 48.868 | 49.896 |
Depreciation / Amortization | 2.702 | 2.657 | 5.969 | 2.846 | 2.799 |
異常費用(收入) | 8.602 | 5.811 | 8.052 | 26.216 | 4.748 |
營業收入 | 105.432 | 96.71 | 104.573 | 97.659 | 122.157 |
利息收入(費用),非經營淨值 | -3.054 | 11.954 | 1.387 | -2.452 | -6.521 |
其他,淨值 | -0.062 | 0.123 | -0.123 | 0.511 | -0.112 |
稅前淨收入 | 102.316 | 108.787 | 105.837 | 95.718 | 115.524 |
稅後淨收入 | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
未計算非常項目前的淨收益 | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
淨收入 | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
普通股股東可獲收益 (不含非經常性項目) | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
普通股股東可獲收益 (含非經常性項目) | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
攤薄淨收入 | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
攤薄後加權平均股 | 230.517 | 230.602 | 230.358 | 230.084 | 229.938 |
扣除特別項目的每股攤薄盈利 | 0.35046 | 0.36875 | 0.38568 | 0.3581 | 0.42038 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | 0.37992 | 0.38845 | 0.41502 | 0.45618 | 0.43766 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 2393.95 | 2109.6 | 1624.41 | 1570.25 | 2155.06 |
現金和短期投資 | 1418.27 | 1065.3 | 715.233 | 753.233 | 1393.69 |
现金 | 122.314 | 235.381 | 245.373 | 189.569 | 208.083 |
短期投資 | 687.597 | 184.785 | 117.249 | 563.664 | 1185.6 |
應收賬款總額,淨額 | 434.068 | 469.663 | 486.605 | 484.608 | 422.091 |
應收賬款 - 貿易,淨額 | 333.518 | 376.213 | 389.058 | 385.117 | 351.612 |
總庫存 | 357.96 | 327.525 | 291.181 | 170.704 | 162.912 |
預付的費用 | 50.958 | 60.629 | 61.159 | 45.409 | 48.25 |
其他流動資産,總計 | 132.7 | 186.484 | 70.227 | 116.294 | 128.122 |
總資産 | 6287.73 | 6146.95 | 5869.62 | 5235.62 | 5748.33 |
物業/廠房/設備,總計 - 淨額 | 757.693 | 739.077 | 661.894 | 455.243 | 511.659 |
物業/廠房/設備,總計 - 總額 | 1260.66 | 1371.49 | 1292.34 | 1154.37 | 1115.09 |
累計折舊,總計 | -502.967 | -632.416 | -630.443 | -699.13 | -603.43 |
商譽,淨額 | 2352.57 | 2350.76 | 2364.03 | 2140.5 | 2108.54 |
無形資産,淨額 | 544.796 | 627.436 | 726.194 | 632.434 | 475.043 |
其他長期資産,總計 | 215.225 | 294.676 | 488.995 | 356.488 | 437.434 |
流動負債總額 | 974.523 | 1517.47 | 572.175 | 951.345 | 972.189 |
應付賬款 | 98.734 | 101.224 | 118.153 | 84.767 | 69.415 |
預提費用 | 215.702 | 219.936 | 220.755 | 332.151 | 209.748 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 389.552 | 847.626 | 42.539 | 285.244 | 503.177 |
其他流動負債,總計 | 270.535 | 348.684 | 190.728 | 249.183 | 189.849 |
負債總額 | 2821.12 | 3050.4 | 3071.78 | 2699.02 | 3113.36 |
長期債務總額 | 1471.9 | 1094.14 | 1880.21 | 1421.11 | 1671.09 |
長期債務 | 1471.9 | 1094.14 | 1880.21 | 1421.11 | 1671.09 |
遞延所得稅 | 17.5 | 37.591 | 39.216 | 23.442 | 63.411 |
少數股權 | |||||
其他負債,總計 | 357.203 | 401.199 | 580.179 | 303.13 | 406.672 |
總權益 | 3466.61 | 3096.55 | 2797.84 | 2536.59 | 2634.97 |
普通股 | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
額外實收資本 | 1868.02 | 1818.51 | 1834.17 | 1777.02 | 1742.19 |
留存收益(累計赤字) | 2160.17 | 1791.74 | 1323.09 | 1178.46 | 1379.62 |
Treasury Stock - Common | -160.188 | -189.73 | -118.301 | -111.966 | -178.903 |
Unrealized Gain (Loss) | 0 | ||||
其他權益,總計 | -404.091 | -326.67 | -243.822 | -309.619 | -310.644 |
總負債和股東權益 | 6287.73 | 6146.95 | 5869.62 | 5235.62 | 5748.33 |
已發行普通股總數 | 227.716 | 227.074 | 227.985 | 227.752 | 225.509 |
長期投資 | 23.5 | 25.4 | 4.1 | 80.7 | 60.6 |
應收票據 - 長期 | |||||
現金等價物 | 608.355 | 645.135 | 352.611 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 1962.39 | 2311.43 | 2251.32 | 2393.95 | 2755.51 |
現金和短期投資 | 1015.78 | 1331.9 | 1287.34 | 1418.27 | 1886.98 |
現金等價物 | 579.935 | 609.549 | 359.18 | 730.669 | 1271.6 |
短期投資 | 435.843 | 722.352 | 928.161 | 687.597 | 615.387 |
應收賬款總額,淨額 | 326.69 | 327.899 | 329.544 | 333.518 | 323.175 |
應收賬款 - 貿易,淨額 | 326.69 | 327.899 | 329.544 | 333.518 | 323.175 |
總庫存 | 399.207 | 391.989 | 380.824 | 357.96 | 323.472 |
預付的費用 | 220.715 | 259.639 | 253.609 | 284.208 | 221.882 |
總資産 | 5906.7 | 6347.27 | 6278.95 | 6287.73 | 6516.62 |
物業/廠房/設備,總計 - 淨額 | 706.02 | 706.84 | 691.055 | 662.17 | 590.983 |
物業/廠房/設備,總計 - 總額 | 1252.48 | 1222.98 | 1165.14 | 1075.87 | |
累計折舊,總計 | -545.641 | -531.924 | -502.967 | -484.887 | |
商譽,淨額 | 2434.47 | 2456.54 | 2454.08 | 2352.57 | 2299.26 |
無形資産,淨額 | 542.604 | 570.192 | 585.021 | 544.796 | 551.587 |
長期投資 | 27.3 | 27.7 | 23.5 | 21 | |
其他長期資産,總計 | 261.217 | 274.97 | 269.778 | 310.748 | 298.273 |
流動負債總額 | 524.371 | 978.45 | 890.244 | 974.523 | 1497.54 |
應付賬款 | 76.887 | 83.939 | 84.386 | 98.734 | 82.836 |
預提費用 | 346.876 | 325.962 | 341.615 | 417.237 | 487.562 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | |
長期債務的當前部分/資本租賃 | 100.608 | 500.149 | 393.243 | 389.552 | 866.04 |
其他流動負債,總計 | 68.4 | 71 | 69 | 61.1 | |
負債總額 | 2213 | 2723.66 | 2717.78 | 2821.12 | 3188.86 |
長期債務總額 | 1382.36 | 1387.94 | 1486.71 | 1471.9 | 1423.21 |
長期債務 | 1382.36 | 1387.94 | 1486.71 | 1471.9 | 1423.21 |
遞延所得稅 | 17.5 | 9.387 | |||
其他負債,總計 | 306.268 | 357.273 | 340.827 | 357.203 | 258.726 |
總權益 | 3693.7 | 3623.61 | 3561.18 | 3466.61 | 3327.76 |
普通股 | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
額外實收資本 | 1903.08 | 1890.02 | 1882.16 | 1868.02 | 1854.36 |
留存收益(累計赤字) | 2360.88 | 2283.06 | 2215.43 | 2160.17 | 2072.57 |
Treasury Stock - Common | -134.277 | -134.277 | -142.855 | -160.188 | -160.943 |
其他權益,總計 | -438.687 | -417.902 | -396.261 | -404.091 | -440.933 |
總負債和股東權益 | 5906.7 | 6347.27 | 6278.95 | 6287.73 | 6516.62 |
已發行普通股總數 | 228.182 | 228.182 | 228.035 | 227.716 | 227.7 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
经营活动产生的现金 | 715.264 | 639.001 | 457.806 | 330.843 | 359.496 |
经营活动产生的现金 | 208.397 | 214.931 | 205.014 | 231.458 | 206.436 |
Deferred Taxes | -9.603 | -5.288 | -6.706 | -55.362 | -23.272 |
非现金物品 | 125.14 | 46.771 | -27.423 | 240.526 | 81.111 |
Cash Taxes Paid | 98.565 | 102.083 | 42.572 | 41.474 | 29.317 |
已付现金利息 | 23.208 | 21.588 | 25.351 | 29.721 | 25.902 |
营运资金的变化 | -31.881 | -130.012 | -72.267 | -44.324 | -95.159 |
投资活动产生的现金 | -726.763 | -202.426 | -443.281 | -222.278 | -211.356 |
资本支出 | -149.336 | -206.534 | -304.237 | -274.884 | -150.763 |
其他投资现金流量项目,总计 | -577.427 | 4.108 | -139.044 | 52.606 | -60.593 |
融资活动产生的现金 | -125.803 | -150.366 | -50.127 | -639.08 | 360.408 |
融资现金流项目 | -17.373 | -16.953 | -23.451 | -61.279 | -8.019 |
股票的发行(报废),净额 | 0.121 | -92.068 | 8.876 | 62.362 | -27.867 |
债务的发行(退还),净额 | -108.551 | -41.345 | -35.552 | -640.163 | 396.294 |
外汇效应 | -12.545 | -3.677 | 4.196 | 0.826 | -7.183 |
现金净变化 | -149.847 | 282.532 | -31.406 | -529.689 | 501.365 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 85.035 | 423.211 | 334.367 | 251.973 | 155.312 |
Cash From Operating Activities | 71.926 | 715.264 | 590.945 | 379.363 | 207.41 |
Cash From Operating Activities | 52.061 | 208.397 | 153.725 | 103.408 | 52.998 |
Deferred Taxes | -4.341 | -9.603 | -40.196 | -3.95 | 0.615 |
Non-Cash Items | 13.323 | 125.14 | 95.413 | 47.519 | 21.86 |
Changes in Working Capital | -74.152 | -31.881 | 47.636 | -19.587 | -23.375 |
Cash From Investing Activities | -433.847 | -726.763 | -602.237 | -557.789 | -306.252 |
Capital Expenditures | -38.409 | -149.336 | -102.745 | -76.024 | -38.415 |
Other Investing Cash Flow Items, Total | -395.438 | -577.427 | -499.492 | -481.765 | -267.837 |
Cash From Financing Activities | -9.828 | -125.803 | 420.57 | 12.549 | -10.658 |
Financing Cash Flow Items | -9.903 | -17.373 | 49.011 | 12.443 | -10.687 |
Issuance (Retirement) of Stock, Net | 0.075 | 0.121 | 0.107 | 0.106 | 0.029 |
Issuance (Retirement) of Debt, Net | -108.551 | 371.452 | 0 | 0 | |
Foreign Exchange Effects | 0.26 | -12.545 | -18.197 | -8.105 | -0.501 |
Net Change in Cash | -371.489 | -149.847 | 391.081 | -173.982 | -110.001 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
MFS Investment Management | Investment Advisor/Hedge Fund | 8.7992 | 20078128 | -102677 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.722 | 8492990 | 141460 | 2023-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 3.0334 | 6921770 | 10881 | 2023-05-09 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 1.9838 | 4526635 | 1663553 | 2023-06-30 | LOW |
Fidelity International | Investment Advisor | 1.9505 | 4450800 | 1412750 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.9066 | 4350561 | -90657 | 2023-06-30 | LOW |
UBS Asset Management (Switzerland) | Investment Advisor | 1.8754 | 4279398 | 765282 | 2022-12-19 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.466 | 3345086 | 580634 | 2023-06-30 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 1.4559 | 3322170 | 25311 | 2023-09-30 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 1.2493 | 2850742 | 388353 | 2023-06-30 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.163 | 2653783 | 522140 | 2023-06-30 | HIGH |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 1.1065 | 2524765 | -14911 | 2023-08-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9641 | 2200010 | -25442 | 2023-06-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.9014 | 2056848 | 327955 | 2023-06-30 | LOW |
Millennium Management LLC | Hedge Fund | 0.857 | 1955605 | 1619566 | 2023-06-30 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.8515 | 1943006 | -12785 | 2023-06-30 | MED |
BofA Global Research (US) | Research Firm | 0.8364 | 1908531 | -182510 | 2023-06-30 | LOW |
HSBC Global Asset Management (UK) Limited | Investment Advisor/Hedge Fund | 0.8349 | 1905156 | -72184 | 2023-06-30 | LOW |
PRIMECAP Management Company | Investment Advisor | 0.8182 | 1867017 | -3540 | 2023-06-30 | |
Nekton Capital Limited | Hedge Fund | 0.7597 | 1733397 | -49500 | 2023-06-30 | HIGH |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Qiagen Company profile
关于 Qiagen NV
Qiagen NV是一家位于荷兰的控股公司。 公司从事提供从样本到洞察力的解决方案,将生物样本转化为分子洞察力。 其 "从样本到洞察力 "解决方案整合了样本和检测技术、生物信息学和自动化系统。 其样品技术用于从血液或其他液体、组织、植物或其他材料中分离和制备脱氧核糖核酸(DNA)、核糖核酸(RNA)和蛋白质。 其化验技术使这些生物大分子可见,以便进行分析,如识别病原体的遗传信息或肿瘤中的基因突变。 其生物信息学解决方案解释数据以提供可操作的见解。 公司基于聚合酶链式反应(PCR)、下一代测序(NGS)和其他技术的自动化平台将这些技术在分子测试工作流程中从样品到洞察力联系在一起。
Industry: | Biotechnology & Medical Research (NEC) |
Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球570,000万多名交易者的一份子,选择利用Capital.com进行交易吧。